Please check your internet connection and try again.
# Methycobalime (methylcobalamin)
## Overview
Methycobalime, containing the active form of vitamin B12, methylcobalamin, is a water-soluble vitamin essential for DNA synthesis, red blood cell maturation, and neurological function.
## Primary Indications
* Vitamin B12 deficiency (pernicious anemia, malabsorption syndromes).
* Diabetic neuropathy.
* Hyperhomocysteinemia (as adjunct therapy).
## Adult Dosing
* **Vitamin B12 Deficiency:** Oral: Typically 1000-2000 mcg daily. Intramuscular or subcutaneous: 1000 mcg daily for one week, then 1000 mcg weekly for one month, then 1000 mcg monthly for life or as directed by protocol. Parenteral doses are generally higher for initial repletion.
* **Diabetic Neuropathy:** Oral: 1500 mcg daily.
* **Hyperhomocysteinemia:** Oral: 1000 mcg daily (often in combination with folic acid and vitamin B6).
Exact dosing and route for initial treatment and maintenance for vitamin B12 deficiency may vary based on clinical guidelines and patient response.
## Pediatric Dosing
* **Vitamin B12 Deficiency:** Oral: 1000-2000 mcg daily. Parenteral: Similar dosing to adults, adjusted for weight, often 1000 mcg/day for 1 week, then 1000 mcg/week for 1 month, then 1000 mcg/month. Specific pediatric guidelines should be consulted.
## Dose Adjustments
No dose adjustment is typically required for renal or hepatic impairment, though caution is advised in severe cases.
## Contraindications
* Hypersensitivity to cobalt, vitamin B12, or any component of the formulation.
## Adverse Effects
Generally well-tolerated. Potential adverse effects include:
* Nausea, vomiting, diarrhea.
* Headache.
* Skin rash, itching.
* Anaphylaxis (rare).
## Key Drug Interactions
* **Metformin:** May decrease absorption of vitamin B12. Monitor B12 levels.
* **Proton Pump Inhibitors (PPIs) & H2 Blockers:** May decrease absorption of vitamin B12. Monitor B12 levels with prolonged use.
* **Chloramphenicol:** May interfere with the hematopoietic response to vitamin B12.
## Monitoring
* Serum vitamin B12 levels.
* Complete blood count (CBC) to assess hematological response.
* Neurological status for improvement in deficiency symptoms.
## Clinical Pearls
* Methylcobalamin is the active coenzyme form of vitamin B12 and does not require metabolic conversion.
* Oral absorption is limited; parenteral administration is often preferred for severe deficiency or malabsorption.
* Monitor for potential masking of folate deficiency if only folate is supplemented without B12.
***
*Disclaimer: This information is intended for clinical professionals. Always consult the official prescribing information and current clinical guidelines for the most up-to-date and complete information before making any treatment decisions.*
